Delphine Lebon

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

Journal: Leukemia

Published: April 14, 2026

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

Journal: Blood cancer journal

Published: March 11, 2026

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 11, 2026

Nosocomial invasive Aspergillus calidoustus infection in a CAR-T cell-treated patient with concomitant Aspergillus fumigatus respiratory infection.

Nosocomial invasive Aspergillus calidoustus infection in a CAR-T cell-treated patient with concomitant Aspergillus fumigatus respiratory infection.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: December 24, 2025

B-Cell Differentiation of Human Hematopoietic Progenitors Is Efficiently Supported by Wharton Jelly-Derived Mesenchymal Stem Cells.

B-Cell Differentiation of Human Hematopoietic Progenitors Is Efficiently Supported by Wharton Jelly-Derived Mesenchymal Stem Cells.

Journal: European journal of immunology

Published: August 26, 2025

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Journal: Leukemia

Published: August 25, 2025

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Journal: Leukemia

Published: August 25, 2025

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.

Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study.

Journal: Blood cancer journal

Published: August 06, 2025

Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia.

Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia.

Journal: British journal of haematology

Published: June 19, 2025

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.

Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.

Journal: Blood advances

Published: May 06, 2025

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Myeloid Neoplasms With Erythroid Predominance and Excess Blasts in Young Adults Exhibit Distinct Genetic Profiles.

Journal: European journal of haematology

Published: March 27, 2025

Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia.

Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia.

Journal: Blood cancer journal

Published: March 26, 2025

Showing 1-12 of 59

Last Updated: 09/26/2026